Antinociceptive action of carbamazepine on thermal hypersensitive pain at spinal level in a rat model of adjuvant-induced chronic inflammation

Journal of Anesthesia

Volumn 25, Issue 1, 2011, Pages 78-86

  Iwamoto, Tatsushige ^a   Takasugi, Yoshihiro ^a   Higashino, Hideaki ^a   Ito, Hiroyuki ^a   Koga, Yoshihisa ^a   Nakao, Shinichi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Carbamazepine; Chronic inflammatory pain; Complete Freund's adjuvant; Tetrodotoxin; Voltage gated sodium channel

Indexed keywords

CARBAMAZEPINE; TETRODOTOXIN; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HEAT SENSITIVITY; LATENT PERIOD; LOW DRUG DOSE; NONHUMAN; PAIN; RAT; SPINAL CORD; SPRAGUE DAWLEY RAT; TAIL FLICK TEST;

ANALGESICS, NON-NARCOTIC; ANESTHETICS, LOCAL; ANIMALS; ARTHRITIS, EXPERIMENTAL; CARBAMAZEPINE; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FREUND'S ADJUVANT; HYPESTHESIA; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SPINAL; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SODIUM CHANNEL BLOCKERS; SPINE; TAIL; TETRODOTOXIN;

EID: 79952247552     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-010-1046-7     Document Type: Article

References (27)

1. JK Cheng RR Ji 2008 Intracellular signaling in primary sensory neurons and persistent pain Neurochem Res 33 1970 1978 1:CAS:528:DC%2BD1cXhtFOjtr7O 10.1007/s11064-008-9711-z 18427980
2. R Amir CE Argoff GJ Bennett TR Cummins ME Durieux P Gerner MS Gold F Porreca GR Strichartz 2006 The role of sodium channels in chronic inflammatory and neuropathic pain J Pain 7 S1 S29 1:CAS:528:DC%2BD28XlsFWntbY%3D 10.1016/j.jpain.2006.01.444 16632328
3. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD001133.
4. M Bianchi G Rossoni P Sacerdote AE Panerai F Berti 1995 Carbamazepine exerts anti-inflammatory effects in the rat Eur J Pharmacol 294 71 74 1:CAS:528:DyaK2MXhtVSgsb%2FE 10.1016/0014-2999(95)00516-1 8788417 (Pubitemid 26015036)
5. Landmark CJ. Targets for antiepileptic drugs in the synapse. Med Sci Monit. 2007;13(1):RA1-7.
6. RM Stepanović-Petrović MA Tomić SM Vucković N Kocev ND Ugresić MS Prostran B Bosković 2008 GABAergic mechanisms are involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesia Pharmacology 82 53 58 10.1159/000127841 18434764 (Pubitemid 351931410)
7. S Vucković M Tomić R Stepanović-Petrovic N Ugresic M Prostran B Boskovic 2007 Role of alpha2-adrenoceptors in the local peripheral antinociception by carbamazepine in a rat model of inflammatory mechanical hyperalgesia Methods Find Exp Clin Pharmacol 29 689 696 10.1358/mf.2007.29.10. 1147773 18200332 (Pubitemid 351251360)
8. TS Jensen TL Yaksh 1986 Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat Brain Res 363 99 113 1:CAS:528:DyaL28XotF2ltg%3D%3D 10.1016/0006-8993(86)90662-1 3004644 (Pubitemid 16148024)
9. Y Takasugi M Fuyuta J Sugiura K Yabuta T Iwamoto Y Koga 2008 The effect of sub-MAC anesthesia and the radiation setting on repeated tail flick testing in rats Exp Anim 57 65 72 1:CAS:528:DC%2BD1cXivFeqsLo%3D 10.1538/expanim.57.65 18256520 (Pubitemid 351372570)
10. V Chapman AH Dickenson 1997 Inflammation reveals inhibition of noxious responses of rat spinal neurons by carbamazepine Neuroreport 8 1399 1404 1:CAS:528:DyaK2sXjvVOhtbo%3D 10.1097/00001756-199704140-00016 9172143 (Pubitemid 27242544)
11. V Chapman R Suzuki HL Chamarette LJ Rygh AH Dickenson 1998 Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats Pain 75 261 272 1:CAS:528:DyaK1cXhs1GnsLc%3D 10.1016/S0304-3959(98)00004-9 9583762 (Pubitemid 28160137)
12. D Ardid Y Lamberty A Alloui MA Coudore-Civiale H Klitgaard A Eschalier 2003 Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats Eur J Pharmacol 473 27 33 1:CAS:528:DC%2BD3sXls1Omurc%3D 10.1016/S0014-2999(03) 01933-2 12877934 (Pubitemid 36851625)
13. TS Jensen 1997 Opioids in the brain: supraspinal mechanisms in pain control Acta Anaesthesiol Scand 41 123 132 1:CAS:528:DyaK2sXhs1Omsrc%3D 10.1111/j.1399-6576.1997.tb04626.x 9061095 (Pubitemid 27072915)
14. A Buvanendran JS Kroin JM Kerns SN Nagalla KJ Tuman 2004 Characterization of a new animal model for evaluation of persistent postthoracotomy pain Anesth Analg 99 1453 1460 10.1213/01.ANE.0000134806.61887.0D 15502048 (Pubitemid 39407298)
15. GC Sun TR Werkman A Battefeld JJ Clare WJ Wadman 2007 Carbamazepine and topiramate modulation of transient and persistent sodium currents studied in HEK293 cells expressing the Na(v)1.3 alpha-subunit Epilepsia 48 774 782 1:CAS:528:DC%2BD2sXlsVWgsbY%3D 10.1111/j.1528-1167.2007.01001.x 17381447 (Pubitemid 46587602)
16. PL Sheets C Heers T Stoehr TR Cummins 2008 Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N- benzyl-3-methoxypropanamide], lidocaine, and carbamazepine J Pharmacol Exp Ther 326 89 99 1:CAS:528:DC%2BD1cXotlylsLc%3D 10.1124/jpet.107.133413 18378801 (Pubitemid 351872141)
17. YK Hur IS Choi JH Cho EJ Park JK Choi BJ Choi IS Jang 2008 Effects of carbamazepine and amitriptyline on tetrodotoxin resistant Na+ channels in immature rat trigeminal ganglion neurons Arch Pharm Res 31 178 182 1:CAS:528:DC%2BD1cXjt1Clsrg%3D 10.1007/s12272-001-1138-x 18365687
18. JA Black S Liu M Tanaka TR Cummins SG Waxman 2004 Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain Pain 108 237 247 1:CAS:528:DC%2BD2cXitFejtrs%3D 10.1016/j.pain.2003.12.035 15030943 (Pubitemid 38353046)
19. HJ Gould 3rd JD England RD Soignier P Nolan LD Minor ZP Liu SR Levinson D Paul 2004 Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat J Pain 5 270 280 1:CAS:528:DC%2BD2cXlt1elsL8%3D 10.1016/j.jpain.2004.04.005 15219259 (Pubitemid 38859681)
20. IT Strickland JC Martindale PL Woodhams AJ Reeve IP Chessell DS McQueen 2008 Changes in the expression of NaV1.7, NaV1.8 and NaV1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain Eur J Pain 12 564 572 1:CAS:528: DC%2BD1cXlvVSls7k%3D 10.1016/j.ejpain.2007.09.001 17950013 (Pubitemid 351615304)
21. CF Villarreal D Sachs FQ Cunha CA Parada SH Ferreira 2005 The role of Na(V)1.8 sodium channel in the maintenance of chronic inflammatory hypernociception Neurosci Lett 386 72 77 1:CAS:528:DC%2BD2MXmvVCnsr8%3D 10.1016/j.neulet.2005.04.060 16043287 (Pubitemid 41058934)
22. YC Yang CC Kuo 2002 Inhibition of Na(+) current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker Mol Pharmacol 62 1228 1237 1:CAS:528:DC%2BD38XosVKisrc%3D 10.1124/mol.62.5.1228 12391287 (Pubitemid 35222515)
23. YC Yang CC Kuo 2005 An inactivation stabilizer of the Na+ channel acts as an opportunistic pore blocker modulated by external Na+ J Gen Physiol 125 465 481 1:CAS:528:DC%2BD2MXks1WktL0%3D 10.1085/jgp.200409156 15824190 (Pubitemid 40656739)
24. SD Dib-Hajj AM Binshtok TR Cummins MF Jarvis T Samad K Zimmermann 2009 Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment Brain Res Rev 60 65 83 1:CAS:528:DC%2BD1MXktV2nsbk%3D 10.1016/j.brainresrev.2008.12.005 19150627
25. ER Benjamin F Pruthi S Olanrewaju VI Ilyin G Crumley E Kutlina KJ Valenzano RM Woodward 2006 State-dependent compound inhibition of Nav1.2 sodium channels using the FLIPR Vm dye: on-target and off-target effects of diverse pharmacological agents J Biomol Screen 11 29 39 1:CAS:528:DC%2BD28XisFCisb8%3D 10.1177/1087057105280918 16234337 (Pubitemid 43255779)
26. + channels, and GABA(A) receptors Br J Anaesth 90 199 211 1:CAS:528:DC%2BD3sXit1GqsL4%3D 10.1093/bja/aeg040 12538378 (Pubitemid 36181966)
27. + current and enhanced nociceptor excitability require NaV1.9 J Physiol 586 1077 1087 1:CAS:528:DC%2BD1cXivFaqu7w%3D 10.1113/jphysiol.2007. 147942 18096591 (Pubitemid 351267347)